BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Chinese Patent Office
Queensland Health

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,750,226

« Back to Dashboard

Summary for Patent: 6,750,226

Title: Quinuclidine derivatives and their use as muscarinic M3 receptor ligands
Abstract:A compound according to formula (I) ##STR1## wherein: {character pullout} is a phenyl ring, a C.sub.4 to C.sub.9 heteroaromatic compound containing one or more heteroatoms, or a naphthalenyl, 5,6,7,8-tetrahydronaphthalenyl or biphenyl group; which shows high affinity for muscarinic M.sub.3 receptors (Hm3).
Inventor(s): Forner; Dolors Fernandez (Barcelona, ES), Quinones; Maria Prat (Barcelona, ES), Buil Albero; Maria Antonia (Barcelona, ES)
Assignee: Almirall-Prodesfarma, S.A. (Barcelona, ES)
Application Number:10/047,464
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 6,750,226

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
SpainP9901580Jul 14, 1999

International Patent Family for Patent: 6,750,226

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ukraine73509► Subscribe
TaiwanI284644► Subscribe
Turkey200200768► Subscribe
Slovakia287480► Subscribe
Slovakia432002► Subscribe
Slovenia1200431► Subscribe
Russian Federation2306312► Subscribe
Russian Federation2005121162► Subscribe
Russian Federation2264401► Subscribe
Portugal1200431► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fish and Richardson
Chinese Patent Office
US Army
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: